Levi & Korsinsky Reminds AEVEX Corp. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of October 20, 2026 - AVEX

Notice to pension funds, asset managers, and fiduciaries holding AEVEX Corp. (NYSE: AVEX): a securities class action alleges the IPO offering documents concealed a pre-arranged plan to waive the 180-day lock-up, a disclosure sequence tied to roughly $900 million in erased market capitalization.

NEW YORK--(BUSINESS WIRE)--Levi & Korsinsky, LLP notifies institutional investors in AEVEX Corp. (NYSE: AVEX) that a class action lawsuit has been filed on behalf of shareholders who purchased securities between April 17, 2026 and June 4, 2026. Request an institutional investor loss assessment. You may also contact Joseph E. Levi, Esq. at [e-mail] or [phone].

AEVEX Class A shares fell approximately 16% on June 2, 2026, wiping out more than $700 million in market capitalization, then declined a further 7% on June 5, 2026, erasing roughly $200 million more. Combined, the two sessions are associated with approximately $900 million in lost market value. To be considered for lead plaintiff, investors must file by October 20, 2026.

Notice to Institutional Holders

Funds that acquired AVEX in or traceable to the April 2026 initial public offering may hold among the largest documented positions in the proposed class and sub-class. The pleading asserts that offering documents represented a 180-day lock-up barring the controlling private equity holder from selling until October 13, 2026, while a plan to waive that restriction was allegedly already in place. As averred, the waiver came 41 days after the IPO, clearing the way for a secondary offering of 8,000,000 shares priced at $27.00 per share.

Portfolio Impact Assessment

• Class period exposure: purchases from April 17, 2026 through June 4, 2026, plus shares traceable to the IPO offering documents.
• Two-step decline: 16% on June 2, 2026 and 7% on June 5, 2026, roughly $900 million in aggregate market value.
• Secondary offering net proceeds of $207.9 million allegedly flowed entirely to the controlling stockholder, with the Company receiving nothing.
• Underwriters allegedly shared $8.1 million in additional fees on the secondary offering, following more than $22 million on the $346 million IPO.
• Claims are pleaded under Securities Act Sections 11, 12 and 15 and Exchange Act Sections 10(b) and 20(a).
• Funds with large IPO allocations may face internal review obligations regarding monitoring and preservation of claims.

"Institutional investors play a critical role in securities class actions, and funds with substantial IPO allocations in AEVEX are often best positioned to evaluate the alleged lock-up disclosures at issue here," -- Joseph E. Levi, Esq.

Fiduciary Considerations for Advisers and Trustees

Investment managers, trustees, and plan fiduciaries may have policies requiring documentation of loss exposure and an assessment of whether to seek an active role in pending securities litigation. Loss review is available at no cost and does not obligate a fund to seek appointment.

Contact us to learn more about institutional recovery options or call [phone].

INSTITUTIONAL INVESTOR REPRESENTATION — Levi & Korsinsky, LLP provides sophisticated counsel to institutional investors evaluating lead plaintiff opportunities. The firm has recovered hundreds of millions of dollars. Ranked among ISS Top 50 for seven consecutive years.

Frequently Asked Questions About the AVEX Lawsuit

Q: Who is eligible to join the AVEX investor lawsuit? A: Investors who purchased AVEX stock or securities between April 17, 2026 and June 4, 2026 and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses -- not on whether you still hold the shares.

Q: What specific misstatements does the AVEX lawsuit allege? A: The complaint alleges AEVEX Corp. made materially false or misleading statements regarding the permanence of the 180-day IPO lock-up restricting its controlling stockholder during the Class Period. When the secondary offering filings disclosed that underwriters had agreed to waive those lock-up restrictions, the stock price declined sharply.

Q: What court was the AVEX class action filed in? A: The case was filed in the United States District Court for the Southern District of California, governed by the Private Securities Litigation Reform Act of 1995.

Q: What is a lead plaintiff and why does it matter? A: A lead plaintiff is the investor appointed by the court to represent the entire class. Lead plaintiffs are typically investors with the largest documented losses. Being appointed does not increase individual recovery but gives direct oversight of how the case is run.

Q: What happens after I contact Levi & Korsinsky? A: An attorney will review your trading history at no cost and provide an initial assessment of your potential eligibility.

Q: What if I already sold my AVEX shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought during the Class Period and sold at a loss may still be eligible to participate.

Q: What does it cost me to participate? A: There is no upfront cost to submit your information and review whether you may be eligible to recover. Should you choose to participate in the securities class action, they are generally handled on a contingency basis, with any attorneys' fees and expenses subject to court approval.

Q: What if I live outside the United States? A: U.S. securities class actions generally cover purchases on U.S. exchanges regardless of the investor's country of residence.

Attorney Advertising. Prior results do not guarantee similar outcomes.